Chester County News and Community Website
WASHINGTON, D.C. — Federal health officials announced that manufacturers of 15 high-cost prescription drugs have agreed to participate in the next round of Medicare drug price negotiations, a program designed …
Drugmakers Agree to Join Next Round of Medicare Price Negotiations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced new draft guidance aimed at reducing the cost and complexity of developing biosimilar medicines, a move the agency says could …
FDA Moves to Cut Costs for Biosimilar Drug Development Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration is rolling out a sweeping set of initiatives aimed at reshaping the nation’s drug and food systems, launching a new pilot …
FDA Unveils Triple Push: Drug Onshoring, Cleaner Food Labels, GLP-1 Crackdown Read More
WASHINGTON, D.C. — President Donald Trump and British Prime Minister Keir Starmer have reached an agreement in principle on pharmaceutical pricing that U.S. officials say could reshape the global drug …
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance Read More
WILMINGTON, DE — A $30 million federal research initiative is taking aim at one of drug development’s most stubborn and costly blind spots: predicting how the human heart will respond …
Virtual Hearts, Real Stakes: $30M ARPA-H Bet Targets Drug Cardiac Risk Read More
WASHINGTON, D.C. — The United States and the United Kingdom reached a sweeping agreement in principle last week to rebalance pharmaceutical pricing between the two nations, marking a rare international …
U.S. Strikes Breakthrough Drug-Pricing Deal With U.K., Promising Major Shift in Global Pharma Costs Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration announced a sweeping set of reforms and enforcement actions last week aimed at lowering prescription drug costs and protecting children from …
FDA Cracks Down on Unapproved Fluoride Drugs, Fast-Tracks Cheaper Biologic Alternatives Read More
WASHINGTON, D.C. — President Donald J. Trump on Friday announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering prescription drug costs and strengthening U.S. manufacturing, part of a …
Trump Administration, AstraZeneca Reach Deal to Cut Drug Prices and Expand U.S. Investment Read More WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) released its final guidance for the third cycle of the Medicare Drug Price Negotiation Program on Tuesday, introducing major …
CMS Finalizes New Medicare Drug Price Rules, Expands Rare Disease Protections Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services last week rolled out a series of high-profile actions aimed at reshaping child health policy, tightening oversight of pharmaceutical …
HHS Unveils Sweeping Child Health Strategy, Moves to Tighten Drug Ads and Block Illegal E-Cigarettes Read More